Zurich Insurance Confirms Mid-Term Targets Ahead of Investor Meeting
By David Sachs
Zurich Insurance confirmed its mid-term targets set last year and set new cost-savings goals ahead of its investor day meeting.
The Switzerland-based insurance company said Thursday that its 2023-to-2025 goals are intact, including its business operating profit return on equity goal of more than 20%. It is also targeting earnings per share growth of 8%, a solvency ratio of at least 160%, and cash remittances above $13.5 billion.
Farmers Exchanges, a service-provider of the wholly-owned Farmers Insurance subsidiary, is targeting a combined ratio of around 99% in 2024, with a surplus ratio of 35%, Zurich said. Zurich said more favorable market conditions on the horizon aid a target surplus ratio range of 34%-38% for that business after finishing 2023 at 28.4%.
Zurich also said it aims to cut costs as a group, targeting an expense ratio of under 10% by 2025.
The company's investor update meeting takes place Thursday at 1100 GMT.
Write to David Sachs at david.sachs@wsj.com
(END) Dow Jones Newswires
November 16, 2023 02:07 ET (07:07 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
How the Tokyo Stock Exchange Is Pushing for Better Capital Allocation
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting